Offer - Urjas Oil for just ₹ 1 X
Rasagin 1 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Parkinson's Disease.
The optimal dosage of Rasagin 1 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Rasagin 1 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Rasagin 1 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Rasagin 1 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Rasagin 1 Tablet's effects on the liver, heart and kidney are discussed below in the Rasagin 1 Tablet related warnings section.
Rasagin 1 Tablet is contraindicated in people with pre-existing medical conditions like Psychosis, Low Blood Pressure (Hypotension) as it can result in adverse effects. Other contraindications of Rasagin 1 Tablet have been discussed in the sections ahead.
Drug interactions for Rasagin 1 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Rasagin 1 Tablet is not safe while driving, and is is not addictive in nature.
Rasagin 1 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rasagin 1 Tablet safe for pregnant women?
Rasagin can have harmful effects in pregnant women. If you experience any discomfort after using Rasagin, then discontinue the use and take your doctor's advice.
Is the use of Rasagin 1 Tablet safe during breastfeeding?
Taking Rasagin may lead to serious side effects if you are breastfeeding. Rasagin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rasagin 1 Tablet on the Kidneys?
Rasagin may have mild side effects on the kidneys.
What is the effect of Rasagin 1 Tablet on the Liver?
Rasagin is rarely harmful for the liver.
What is the effect of Rasagin 1 Tablet on the Heart?
Using Rasagin does not have any harmful effects on the heart.
Rasagin 1 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rasagin 1 Tablet unless your doctor advises you to do so -
Is this Rasagin 1 Tablet habit forming or addictive?
Rasagin 1 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rasagin 1 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Rasagin 1 Tablet is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Yes, in many cases, taking Rasagin 1 Tablet can help with mental disorders.
Interaction between Food and Rasagin 1 Tablet
Eating certain foods may increase the time it takes Rasagin 1 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Rasagin 1 Tablet
Taking alcohol with Rasagin 1 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086